"Investment view remains positive As a result of changes to forecasts our DCF valuation has been revised to A$0.18 (from A$0.20). The key catalysts we expect in the next six months include growing quarterly sales of CardioCel® and the interim results from the HSV-2 vaccine trial"
Bring on positive news and an increase in sales and we will be off again. Not thinking of negative stuff today...on this lovely Victorian public holiday for a football match...only in Aus!
GO HAWKS!!
http://www.admedus.com/au/analystreports/
"Investment view remains positive As a result of changes to...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.80 |
Change
0.020(0.20%) |
Mkt cap ! $207.1M | |||
| Open | High | Low | Value | Volume |
| $9.85 | $10.78 | $9.60 | $572.9K | 57.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5627 | $9.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.00 | 931 | 1 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |